Merrimack Pharma Will Present Added Data Results in Phase 3 NAPOLI-q Study at ESMO

By: via Benzinga
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced that results of the successful Phase 3 NAPOLI-1 study in metastatic ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.